Cargando…

Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model

Amino acid substitutions I38T and E23K in the influenza polymerase acidic (PA) protein lead to reduced susceptibility to the influenza antiviral drug baloxavir. The in vivo effectiveness of baloxavir and oseltamivir for treatment of these viruses is currently unknown. Using patient-derived influenza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koszalka, Paulina, George, Ankita, Dhanasekaran, Vijaykrishna, Hurt, Aeron C., Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426601/ https://www.ncbi.nlm.nih.gov/pubmed/35938724 http://dx.doi.org/10.1128/mbio.01056-22

Ejemplares similares

A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions
por: Koszalka, Paulina, et al.
Publicado: (2020)

Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model
por: Lee, Leo Y, et al.
Publicado: (2021)

In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses
por: Kuroda, Takayuki, et al.
Publicado: (2023)

Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission
por: Lee, Leo Yi Yang, et al.
Publicado: (2020)

A novel E198K substitution in the PA gene of influenza A virus with reduced susceptibility to baloxavir acid
por: Takizawa, Naoki, et al.
Publicado: (2022)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Influenza antivirals currently in late‐phase clinical trial
por: Koszalka, Paulina, et al.
Publicado: (2017)

2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A
por: Shah, Sunish, et al.
Publicado: (2019)

Preclinical and clinical developments for combination treatment of influenza
por: Koszalka, Paulina, et al.
Publicado: (2022)

The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets
por: Kitano, Mitsutaka, et al.
Publicado: (2020)

Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness
por: Oh, Ding Y., et al.
Publicado: (2016)

Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model
por: Stannard, Harry L., et al.
Publicado: (2022)

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact
por: Oh, Ding Yuan, et al.
Publicado: (2014)

1350. Therapeutic Effects of Baloxavir Marboxil against Influenza A Virus Infection in Ferrets
por: Kitano, Mitsutaka, et al.
Publicado: (2018)

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria- and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs
por: Saim-Mamoun, Amel, et al.
Publicado: (2023)

922. Cost-effectiveness of baloxavir marboxil versus oseltamivir or no treatment for the management of influenza in the United States
por: Hansen, Svenn, et al.
Publicado: (2023)

Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors
por: Jones, Jeremy C., et al.
Publicado: (2018)

Investigating the transmission of baloxavir‐resistant influenza viruses from treated index patients to untreated household contacts in the BLOCKSTONE study
por: Harding, Joanne, et al.
Publicado: (2023)

1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
por: Neuberger, Eddie, et al.
Publicado: (2020)

A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023
por: Takashita, Emi, et al.
Publicado: (2023)

Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir
por: Nezu, Keiko, et al.
Publicado: (2023)

A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity
por: Oh, Ding Yuan, et al.
Publicado: (2015)

97. Competition Experiments for the Baloxavir-Resistant I38T Influenza A Mutant
por: Checkmahomed, Liva, et al.
Publicado: (2019)

Oseltamivir and baloxavir: Dual treatment for rapidly developing ARDS on a patient with renal disease
por: Tobar Vega, Pool, et al.
Publicado: (2020)

Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil
por: Nakauchi, Mina, et al.
Publicado: (2020)

Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs
por: Tare, Deeksha S., et al.
Publicado: (2019)

Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets
por: Mifsud, Edin J, et al.
Publicado: (2022)

PA01.38. Role of panchakarma therapies in depressive disorder
por: Ranjan, Mridul, et al.
Publicado: (2012)

Genome Sequence of Pseudomonas chlororaphis Strain PA23
por: Loewen, Peter C., et al.
Publicado: (2014)

Modeling mitigation of influenza epidemics by baloxavir
por: Du, Zhanwei, et al.
Publicado: (2020)

Author Correction for Jones et al., “Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors”
por: Jones, Jeremy C., et al.
Publicado: (2018)

Impact of influenza PA-X on host response
por: Hayashi, Tsuyoshi, et al.
Publicado: (2015)

Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir
por: Marriott, Anthony C., et al.
Publicado: (2014)

LEP1 cryoplants (PA4/PA8)
por: Barth, K, et al.
Publicado: (2000)

Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?
por: Hurt, Aeron, et al.
Publicado: (2017)

Sympathy for t-PA
por: Van Epps, Heather L.
Publicado: (2006)

919. Household Flu Transmission and Healthcare Resource Use among Patients Treated with Baloxavir versus Oseltamivir for Influenza: An Outpatient Prospective Survey in the United States
por: Best, Jennie H, et al.
Publicado: (2023)

På tærkslen til nyt gennembrudf på fysikkens område
por: Thomsen, K E
Publicado: (1981)

Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database( )
por: Miyazawa, Shogo, et al.
Publicado: (2022)

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient
por: Hurt, Aeron C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r21ksjlfrk42ugc2v4gnj5ubpo